Premium
Collegium Pharmaceutical Inc (COLL)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Dr. John Gordon FreundIndependent Director | -20,00 | 681,00 | Vente | 34,05 | 42,41k | -0,05% |
| 2026-05-15 | Dr. John Gordon FreundIndependent Director | -4,13k | 74,49k | Derivative Exercise and Sale | 16,49 - 34,54 | 42,43k | - |
| 2026-05-15 | Dr. John Gordon FreundIndependent Director | 4,57k | 75,41k | Derivative Exercise and Retained Stock | 16,49 | 42,43k | 12,08% |
| 2026-05-13 | Ms. Nancy S. LurkerIndependent Director | -4,50k | 161,86k | Vente | 35,97 | 8,23k | -35,36% |
| 2026-05-11 | Mr. Garen G. BohlinIndependent Director | -8,70k | 180,03k | Derivative Exercise and Sale | 16,49 - 37,18 | 2,25k | - |
| 2026-03-17 | Mr. David DieterExec. VP, General Counsel & Corporate Secretary | -8,84k | 315,76k | Sale to Issuer | 35,72 | 68,23k | -11,47% |
| 2026-03-18 | Mr. David DieterExec. VP, General Counsel & Corporate Secretary | -13,98k | 488,10k | Automatic Disposition | 34,92 | 77,07k | -15,35% |
| 2026-03-09 | Mr. David DieterExec. VP, General Counsel & Corporate Secretary | -6,22k | 228,11k | Automatic Disposition | 36,65 | 91,05k | -6,40% |
| 2026-03-03 | Mr. Scott DreyerInitié | -49,98k | 2,02M | Automatic Disposition | 40,36 - 40,99 | 382,00 | -99,24% |
| 2026-02-10 | Dr. Thomas B. SmithExec. VP & Chief Medical Officer | -17,44k | 815,09k | Sale to Issuer | 46,75 | 35,81k | -32,74% |
| 2026-02-10 | Mr. David DieterExec. VP, General Counsel & Corporate Secretary | -2,78k | 130,01k | Sale to Issuer | 46,75 | 97,27k | -2,78% |
| 2026-02-10 | Ms. Colleen TupperExec. VP & CFO | -38,54k | 1,80M | Sale to Issuer | 46,75 | 61,31k | -38,60% |
| 2026-02-10 | Mr. Vikram KarnaniCEO, President & Director | -11,30k | 528,09k | Sale to Issuer | 46,75 | 39,12k | -22,41% |
| 2026-02-10 | Mr. Scott DreyerInitié | -31,59k | 1,48M | Sale to Issuer | 46,75 | 38,04k | -45,37% |
| 2025-12-08 | Mr. Scott DreyerInitié | -17,60k | 568,02k | Derivative Exercise and Sale | 15,90 - 48,66 | 1,00 | - |
| 2025-12-05 | Dr. Rita J. Balice-GordonIndependent Director | -3,65k | 171,67k | Vente | 47,03 | 42,84k | -7,85% |
| 2025-11-12 | Mr. Vikram KarnaniCEO, President & Director | -8,98k | 425,35k | Sale to Issuer | 47,35 | 17,51k | -33,91% |
| 2025-11-12 | Dr. John A. FallonInitié | -34,85k | 1,21M | Derivative Exercise and Sale | 9,33 - 47,21 | 54,84k | - |
| 2025-11-06 | Ms. Colleen TupperExec. VP & CFO | -30,00k | 1,22M | Automatic Disposition | 40,38 - 41,28 | 12,05k | -71,34% |
| 2025-08-29 | Dr. Thomas B. SmithExec. VP & Chief Medical Officer | -17,48k | 671,58k | Vente | 38,42 | 273,00 | -98,46% |
| 2025-08-18 | Mr. Scott DreyerInitié | -16,39k | 276,43k | Derivative Exercise and Sale | 21,34 - 38,21 | 1,00 | - |
| 2025-08-15 | Mr. Gino SantiniIndependent Chairman | 9,60k | 129,05k | Derivative Exercise and Retained Stock | 13,45 | 35,04k | 37,71% |
| 2025-08-15 | Mr. Gino SantiniIndependent Chairman | -5,41k | 128,32k | Derivative Exercise and Sale | 13,45 - 37,19 | 35,04k | - |
| 2025-08-13 | Mr. Scott DreyerInitié | -4,86k | 81,15k | Derivative Exercise and Sale | 21,34 - 38,03 | 1,00 | - |
| 2025-08-13 | Rubric Capital Management LPSociété | -25,00k | 946,25k | Vente | 37,85 | 3,13M | -0,79% |
| 2025-08-08 | Dr. John Gordon FreundIndependent Director | -11,66k | 400,64k | Vente | 34,36 | 42,41k | -21,56% |
| 2025-06-09 | Dr. John Gordon FreundIndependent Director | 8,40k | 112,97k | Derivative Exercise and Retained Stock | 13,45 | 54,07k | 18,39% |
| 2025-06-09 | Dr. John Gordon FreundIndependent Director | -6,60k | 113,37k | Derivative Exercise and Sale | 13,45 - 30,62 | 54,07k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
